Astera Labs Sees Unusually High Options Volume (NASDAQ:ALAB)

Astera Labs, Inc. (NASDAQ:ALAB) was the recipient of unusually large options trading activity on Tuesday. Stock investors purchased 21,392 call options on the company. This is an increase of approximately 29% compared to the average volume of 16,569 call options.

Astera Labs Trading Down 4.9 %

Shares of NASDAQ:ALAB opened at $87.50 on Thursday. Astera Labs has a twelve month low of $36.22 and a twelve month high of $147.39. The company has a 50-day moving average price of $121.90 and a two-hundred day moving average price of $82.86.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. As a group, sell-side analysts anticipate that Astera Labs will post -0.45 EPS for the current fiscal year.

Analyst Ratings Changes

ALAB has been the subject of several analyst reports. Roth Mkm lifted their price objective on shares of Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Northland Capmk upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Stifel Nicolaus upped their target price on shares of Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, January 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $140.00 price objective on shares of Astera Labs in a research note on Tuesday. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $115.33.

Insiders Place Their Bets

In other Astera Labs news, CFO Michael Truett Tate sold 16,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.84, for a total value of $1,885,440.00. Following the transaction, the chief financial officer now owns 1,412,888 shares in the company, valued at approximately $166,494,721.92. The trade was a 1.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Stefan A. Dyckerhoff sold 197,297 shares of Astera Labs stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the transaction, the director now owns 6,148 shares in the company, valued at approximately $556,455.48. The trade was a 96.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 846,452 shares of company stock valued at $86,427,256 over the last quarter.

Institutional Investors Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in ALAB. Whittier Trust Co. of Nevada Inc. bought a new stake in Astera Labs in the fourth quarter worth $25,000. Steward Partners Investment Advisory LLC lifted its holdings in shares of Astera Labs by 99.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after purchasing an additional 99 shares during the period. Kestra Investment Management LLC purchased a new position in Astera Labs during the fourth quarter valued at approximately $28,000. Geneos Wealth Management Inc. purchased a new stake in shares of Astera Labs in the fourth quarter valued at approximately $36,000. Finally, Global Retirement Partners LLC increased its position in shares of Astera Labs by 3,155.6% in the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock valued at $39,000 after buying an additional 284 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.